Risk factors and outcome of COVID-19 in patients with hematological malignanciesJosé Luís Piñana, Anna Sureda, Rodrigo Martino et al.|Experimental Hematology and Oncology|2020Cited by 159
Long‐Term Safety Profile of Ruxolitinib in Chronic Myeloproliferative Neoplasms: A Comprehensive Real‐World AnalysisAlberto Blanco Sánchez, Joaquín Martínez‐López, Nieves López‐Muñoz et al.|eJHaem|2025Cited by 3